Peptide and peptide analog transport systems at the blood-CSF barrier

被引:106
作者
Smith, DE
Johanson, CE
Keep, RF
机构
[1] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Upjohn Ctr Clin Pharmacol, Ann Arbor, MI 48109 USA
[3] Rhode Isl Hosp, Dept Neurosurg, Providence, RI 02903 USA
[4] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA
关键词
peptide transporters; proton-coupled oligopeptide transporters; PEPT2; choroid plexus; central nervous system; drug delivery; drug efflux; neuropeptides; hormones; peptidomimetics;
D O I
10.1016/j.addr.2004.07.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to being the main source of cerebrospinal fluid (CSF) secretion, the choroid plexuses are involved in the supply and distribution of peptides to brain, the removal of toxic metabolites, the excretion of xenobiotics, and the delivery of drugs as an alternative route to the blood-brain barrier (BBB). The discovery of proton-coupled oligopeptide transporters in choroid plexus has generated considerable interest regarding their physiologic role at the blood-cerebrospinal fluid interface and their potential for peptide/antagonist pharmacotherapy in the central nervous system. Many of the same factors that affect the disposition of naturally occurring peptides in brain will also affect the disposition of exogenously delivered peptide or peptidomimetic drugs. Therefore, this review addresses three main areas: (1) choroid plexus structure, physiology, and barrier function in relation to peptide transport; (2) polypeptide transport and secretion mechanisms into cerebrospinal fluid; and (3) molecular physiology. expression, and functional activity of proton-coupled oligopeptide transporters in choroid plexus. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:1765 / 1791
页数:27
相关论文
共 188 条
[1]   Insulin and leptin combine additively to reduce food intake and body weight in rats [J].
Air, EL ;
Benoit, SC ;
Clegg, DJ ;
Seeley, RJ ;
Woods, SC .
ENDOCRINOLOGY, 2002, 143 (06) :2449-2452
[2]  
Akarawut W, 1998, J PHARMACOL EXP THER, V287, P684
[3]  
[Anonymous], 1985, Experimental biology of the lymphatic circulation
[4]   PROLACTIN IN HUMAN CEREBROSPINAL-FLUID [J].
ASSIES, J ;
SCHELLEKENS, APM ;
TOUBER, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 46 (04) :576-586
[5]  
Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO
[6]  
2-#
[7]   SATURABLE TRANSPORT OF PEPTIDES ACROSS THE BLOOD-BRAIN-BARRIER [J].
BANKS, WA ;
KASTIN, AJ .
LIFE SCIENCES, 1987, 41 (11) :1319-1338
[8]   Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations [J].
Banks, WA .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (10) :801-809
[9]   Leptin enters the brain by a saturable system independent of insulin [J].
Banks, WA ;
Kastin, AJ ;
Huang, WT ;
Jaspan, JB ;
Maness, LM .
PEPTIDES, 1996, 17 (02) :305-311
[10]   Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse [J].
Banks, WA ;
Goulet, M ;
Rusche, JR ;
Niehoff, ML ;
Boismenu, R .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) :1062-1069